Cai Pingping, Zeng Lei, Shi Hualing, Zhang Mengli, Guo Lifang, Ge Yiping
Department of Cosmetic Laser Surgery, Hospital of Dermatology,Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.
Jin hua Municipal Central Hospital, Jin hua, China.
Lasers Med Sci. 2025 Mar 20;40(1):152. doi: 10.1007/s10103-025-04408-9.
To characterize midfrontal erythema and evaluate the clinical efficacy of 595 nm pulsed dye laser treatment for this condition. A total of 85 patients presenting with vascular lesions in the midfrontal area were analyzed who received the pulsed dye laser treatment between 2018 and 2023. The efficacy and safety of the treatment was assessed. The total effective rate of pulsed dye laser treatment for midfrontal erythema was 96.4%, with a cure rate of 69.4%. No adverse event was observed. Patients' ages and color of the skin lesions affected the therapeutic outcomes. Younger patients had higher effective rates. And the patients with pink lesions show higher cure rates than those with purple-red lesions. Pulsed dye laser treatment was effective and safe for the treatment of midline frontal erythema, particularly when initiated early.So We propose the diagnosis of "midfrontal erythema" or "persistent salmon patch" for this condition. Clinical trial number: not applicable.
为了描述额中部红斑的特征并评估595纳米脉冲染料激光治疗该病症的临床疗效。分析了2018年至2023年间共85例在额中部区域出现血管病变并接受脉冲染料激光治疗的患者。评估了治疗的疗效和安全性。脉冲染料激光治疗额中部红斑的总有效率为96.4%，治愈率为69.4%。未观察到不良事件。患者的年龄和皮肤病变颜色影响治疗结果。年轻患者的有效率更高。并且粉红色病变的患者比紫红色病变的患者治愈率更高。脉冲染料激光治疗额中部中线红斑有效且安全，尤其是早期开始治疗时。因此，我们建议将这种病症诊断为“额中部红斑”或“持续性鲑鱼色斑”。临床试验编号：不适用。
